Latent Infection: Clinical Trials

1 trial for Latent Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Latent Infection: new trials by email Literature Review of Latent Infection trials Research Report on Latent Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
I ( isoniazid), II (isoniazid + rifampin ) - Tuberculosis
Phase 4TerminatedHospital Virgen de la Luz2281996-03-012008-12-31

Narrower conditions

Latent Tuberculosis (1)  ·  Tuberculosis (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Mycobacterium Infections (1)

Interventions

Isoniazid (1)  ·  Rifampin (1)

Sponsors

Hospital Virgen de la Luz (1)

Countries

Spain (1)

Top investigators

Maria Paloma Geijo Martinez, MD (1)

Results publications

PMID 17504682